Mortality and costs of acute renal failure associated with amphotericin B therapy

Clinical Infectious Diseases

Volumn 32, Issue 5, 2001, Pages 686-693

  Bates, D W ^a,c   Su, L ^e   Yu, D T ^a,c   Chertow, G M ^f   Seger, D L ^a,c   Gomes, D R J ^e   Dasbach, E J ^e   Platt, R ^b,d  

^a Division of General Medicine   (United States)

^b CHANNING LABORATORY   (United States)

^c Partners Information Systems   (United States)

^d HARVARD PILGRIM HEALTH CARE   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f UCSF Medical Center at Parnassus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CREATININE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE CALCULATION; DRUG EFFICACY; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RESOURCE MANAGEMENT;

ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; COHORT STUDIES; FEMALE; HOSPITAL COSTS; HOSPITALIZATION; HOSPITALS, URBAN; HUMANS; KIDNEY FAILURE, ACUTE; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0035282477     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319211     Document Type: Article

References (36)

1. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
2. Candidemia in a tertiary care hospital: Epidemiology, risk factors, and predictors of mortality
3. Candida infections in surgical patients
4. Hospital-acquired fungemia: Its natural course and cllnical significance
5. Nosocomial fungemia in a large community teaching hospital
6. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: Frequency, characteristics, and evaluation of factors influencing outcome
7. Fungemia in a cancer hospital: Changing frequency, earlier onset, and results of therapy
8. Antifungal treatment in patients with cancer
9. Renal tubular acidosis due to amphotericin B nephrotoxicity
10. Nephrotoxic effects of amphotericin B, including renal tubular acidosis
11. Renal tubular acidosis due to amphotericin B
12. Nephrotoxicity of amphotericin B, with emphasis on changes in tubular function
13. Amiloride prevents amphotericin B related hypokalaemia in neutropenic patients
14. Amphotericin B use in a community hospital, with special emphasis on side effects
15. Drug nephrotoxicity
16. Chronic amphotericin nephropathy: Morphometric, electron microscopic, and functional studies
17. Systemic antifungal agents: Drug interactions of clinical significance
18. Drug-induced nephrotoxicity: Aetiology, clinical features, and management
19. Amphotericin B nephrotoxicity: Increased renal resistance and tubule permeability
20. Risk factors for amphotericin B-associated nephrotoxicity
21. Sodium protects against nephrotoxicity in patients receiving amphotericin B
22. Effect of salt supplementation on amphotericin B nephrotoxicity
23. Independent association between acute renal failure and mortality following cardiac surgery
24. Acute renal failure following bone marrow transplantation: A retrospective study of 272 patients
25. Liposomal amphotericin B: Therapeutic use in the management of fungal infections and visceral leishmaniasis
26. AmBisome (liposomal amphotericin B): A comparative review
27. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia
28. Comparison of alternative weight recalibration methods for diagnosis-related groups
29. The costs of adverse drug events in hospitalized patients
30. Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: Results of a prospective, randomized, controlled study in critically ill patients
31. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis
32. Risk factors for acute renal insufficiency in patients with suspected or documented bacterial pneumonia
33. Renal dysfunction during high-dose cisplatin therapy and autologous hematopoietic stem cell transplantation: Effect of aminoglycoside therapy
34. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy